SCHEMBL19661192

SCHEMBL19661192

CCCCCCCCOc1ccc(-c2nc(-c3ccc(C)cc3C)nc(-c3ccc(C)cc3C)n2)c(OCCCC(C)(C)C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.38
PTPN11 Q06124 3/20 0.38
PLK1 P53350 3/20 0.36
CYP2C9 P11712 2/20 0.36
MOGAT2 Q3SYC2 1/20 0.36
ESR1 P03372 2/20 0.35
TTR P02766 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C8 P10632 1/20 0.35
CHRM1 P11229 1/20 0.35
TSHR P16473 1/20 0.35
ADRA1A P35348 1/20 0.35
PPARG P37231 1/20 0.35
HTR2B P41595 1/20 0.35
PPARA Q07869 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
SLCO1B3 Q9NPD5 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CISD1 Q9NZ45 1/20 0.35
SLCO1B1 Q9Y6L6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23559214 0.93 PDK2 (0.38) PDK2PTPN11PLK1CYP2C9MOGAT2
SCHEMBL19663723 0.92 PTPN11 (0.43) PDK2PTPN11PLK1TSHRACACB
SCHEMBL21574567 0.92 PTPN11 (0.43) PDK2PTPN11PLK1TSHRACACB
SCHEMBL21337962 0.90 ACACB (0.42) PDK2PTPN11PLK1TSHRACACB
SCHEMBL21574515 0.87 PTPN11 (0.39) PDK2PTPN11PLK1ACACBACACA
SCHEMBL23023555 0.87 PTPN11 (0.41) PDK2PTPN11PLK1ACACBACACA
SCHEMBL21574510 0.87 PTPN11 (0.39) PDK2PTPN11PLK1TSHRACACB
SCHEMBL20367064 0.87 PTPN11 (0.39) PDK2PTPN11PLK1TSHRACACB
SCHEMBL24445620 0.87 PTPN11 (0.46) PDK2PTPN11PLK1CYP2C9CYP1A2
SCHEMBL20690907 0.85 PTPN11 (0.38) PDK2PTPN11PLK1TSHRACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365832-A1 SURFACE TREATMENT AGENT DAIKIN INDUSTRIES, LTD. (JP) 2023-11-16 US disclosed
US-20230365832-A1 SURFACE TREATMENT AGENT DAIKIN INDUSTRIES, LTD. (JP) 2023-11-16 US disclosed
US-11814537-B2 Silane compound containing perfluoro (poly ) ether group DAIKIN INDUSTRIES, LTD. (JP) 2023-11-14 US disclosed
US-11814537-B2 Silane compound containing perfluoro (poly ) ether group DAIKIN INDUSTRIES, LTD. (JP) 2023-11-14 US disclosed
US-11760062-B2 Article having surface treatment layer DAIKIN INDUSTRIES, LTD. (JP) 2023-09-19 US disclosed
US-11760062-B2 Article having surface treatment layer DAIKIN INDUSTRIES, LTD. (JP) 2023-09-19 US disclosed
US-20230273348-A1 SURFACE TREATMENT COMPOSITION DAIKIN INDUSTRIES, LTD. (JP) 2023-08-31 US disclosed
US-20230273348-A1 SURFACE TREATMENT COMPOSITION DAIKIN INDUSTRIES, LTD. (JP) 2023-08-31 US disclosed
US-11715831-B2 Electrode and electrochemical device DAIKIN INDUSTRIES, LTD. (JP) 2023-08-01 US disclosed
US-20230227612-A1 CURABLE COMPOSITION DAIKIN INDUSTRIES, LTD. (JP) 2023-07-20 US disclosed
US-10781335-B2 Functional film DAIKIN INDUSTRIES, LTD. (JP) 2020-09-22 US disclosed
US-10731048-B2 2020-08-04 US disclosed
US-20200067097-A1 ELECTRODE AND ELECTROCHEMICAL DEVICE DAIKIN INDUSTRIES, LTD. (JP) 2020-02-27 US disclosed
US-20190308365-A1 PROCESS FOR PRODUCING RECEIVING OBJECT HAVING TRANSFERRED PATTERN DAIKIN INDUSTRIES, LTD. (JP) 2019-10-10 US disclosed
US-20190284431-A1 FUNCTIONAL FILM DAIKIN INDUSTRIES, LTD. (JP) 2019-09-19 US disclosed
US-20190031828-A1 SURFACE TREATMENT AGENT DAIKIN INDUSTRIES, LTD. (JP) 2019-01-31 US disclosed
US-20180030280-A1 SURFACE TREATMENT AGENT DAIKIN INDUSTRIES, LTD. (JP) 2018-02-01 US disclosed
US-20180030280-A1 SURFACE TREATMENT AGENT DAIKIN INDUSTRIES, LTD. (JP) 2018-02-01 US disclosed
US-20170342210-A1 MODIFIED FLUOROOXYMETHYLENE GROUP-CONTAINING PERFLUOROPOLYETHER DAIKIN INDUSTRIES, LTD. (JP) 2017-11-30 US disclosed
US-20170342210-A1 MODIFIED FLUOROOXYMETHYLENE GROUP-CONTAINING PERFLUOROPOLYETHER DAIKIN INDUSTRIES, LTD. (JP) 2017-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180030280-A1 SURFACE TREATMENT AGENT EPCAM, ITGA2, ITGB2 PDK2 3489/4885PTPN11 1015/4885PLK1 1392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.